Effect of pharmaceutical potential endocrine disruptor compounds on protein disulfide isomerase reductase activity using di-eosin-oxidized-glutathione.
about
Characterization of the estradiol-binding site structure of human protein disulfide isomerase (PDI)The X awakens: multifactorial ramifications of sex-specific differences in HIV-1 infection.Succination of Protein Disulfide Isomerase Links Mitochondrial Stress and Endoplasmic Reticulum Stress in the Adipocyte During Diabetes.
P2860
Effect of pharmaceutical potential endocrine disruptor compounds on protein disulfide isomerase reductase activity using di-eosin-oxidized-glutathione.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effect of pharmaceutical poten ...... di-eosin-oxidized-glutathione.
@ast
Effect of pharmaceutical poten ...... di-eosin-oxidized-glutathione.
@en
Effect of pharmaceutical poten ...... di-eosin-oxidized-glutathione.
@nl
type
label
Effect of pharmaceutical poten ...... di-eosin-oxidized-glutathione.
@ast
Effect of pharmaceutical poten ...... di-eosin-oxidized-glutathione.
@en
Effect of pharmaceutical poten ...... di-eosin-oxidized-glutathione.
@nl
prefLabel
Effect of pharmaceutical poten ...... di-eosin-oxidized-glutathione.
@ast
Effect of pharmaceutical poten ...... di-eosin-oxidized-glutathione.
@en
Effect of pharmaceutical poten ...... di-eosin-oxidized-glutathione.
@nl
P2093
P2860
P1433
P1476
Effect of pharmaceutical poten ...... di-eosin-oxidized-glutathione.
@en
P2093
Claire Cahoreau
Danièle Klett
Mélanie Villeret
P2860
P356
10.1371/JOURNAL.PONE.0009507
P407
P577
2010-03-03T00:00:00Z